Analysis of Serum Paraoxonase 1 Using Mass Spectrometry and Lectin Immunoassay in Patients With Alpha-Fetoprotein Negative Hepatocellular Carcinoma

Analysis of Serum Paraoxonase 1 Using Mass Spectrometry and Lectin Immunoassay in Patients With Alpha-Fetoprotein Negative Hepatocellular Carcinoma

The diagnosis of AFP (alpha-fetoprotein)-negative HCC (hepatocellular carcinoma) mostly relies on imaging and pathological examinations, and it lacks valuable and practical markers. Protein N-glycosylation is a crucial post-translation modifying process related to many biological functions in an org...

Full description

Bibliographic Details
Main Authors:	Xinyi Cao, Zhao Cao, Yuyin Shao, Chao Liu, Guoquan Yan, Xinmin Meng, Lei Zhang, Chen Chen, Guiyue Huang, Hong Shu, Haojie Lu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-04-01
Series:	Frontiers in Oncology
Subjects:	alpha-fetoprotein-negative hepatocellular carcinoma PON1 biomarker glycoproteomics mass spectrometry lectin ELISA
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.651421/full

Similar Items

Development of a glycoproteomic strategy to detect more aggressive prostate cancer using lectin-immunoassays for serum fucosylated PSA
by: Ce Wang, et al.
Published: (2019-04-01)

Application of Lectin Microarrays for Biomarker Discovery
by: Dr. Kai Dang, et al.
Published: (2020-03-01)

Use of Aleuria alantia Lectin Affinity Chromatography to Enrich Candidate Biomarkers from the Urine of Patients with Bladder Cancer
by: Sarah R. Ambrose, et al.
Published: (2015-09-01)

Multiple hepatic inflammatory pseudotumors with elevated alpha-fetoprotein and alpha-fetoprotein lectin 3 fraction with various PET accumulations: a case report
by: Masataka Maruno, et al.
Published: (2021-04-01)

Heterogeneities of Site-Specific N-Glycosylation in HCC Tumors With Low and High AFP Concentrations
by: Ting Zhao, et al.
Published: (2020-04-01)

Hepatic inflammatory pseudotumor associated with primary biliary cholangitis and elevated alpha-fetoprotein lectin 3 fraction mimicking hepatocellular carcinoma
by: Sho Endo, et al.
Published: (2018-09-01)

Prognostic value of α-fetoprotein response in treatment of hepatocellular carcinoma
by: JIA Jia
Published: (2013-08-01)

The Clinical Significance of Serum Alpha-fetoprotein in Diagnosing Hepatocellular Carcinoma in a Health Screening Population
by: Young Sun Ko, et al.
Published: (2017-04-01)

Early Detection of Hepatocellular Carcinoma Recurrence Using the Highly Sensitive Fucosylated Fraction of Alpha-Fetoprotein
by: Toru Setsu, et al.
Published: (2017-03-01)

Normal Alpha-Fetoprotein Hepatocellular Carcinoma: Are They Really Normal?
by: Chao-Wei Lee, et al.
Published: (2019-10-01)

Diagnosis of sepsis in dogs by measuring carbonylated proteins (PCOs) and paraoxonase (PON-1)
by: Beatrice Ruggerone, et al.
Published: (2018-06-01)

The alpha-fetoprotein serum is still reliable as a biomarker for the surveillance of hepatocellular carcinoma in Indonesia
by: Chyntia Olivia Maurine Jasirwan, et al.
Published: (2020-07-01)

Combined detection of circulating tumor cells, α-fetoprotein heterogene-3 and α-fetoprotein in the early diagnosis of HCC for the prediction of efficacy, prognosis, recurrence after microwave ablation
by: Jian Zhou, et al.
Published: (2021-05-01)

Nomograms to predict the long‐time prognosis in patients with alpha‐fetoprotein negative hepatocellular carcinoma following radical resection
by: Jian Huang, et al.
Published: (2020-04-01)

Diagnostic value of alpha-fetoprotein combined with neutrophil-to-lymphocyte ratio for hepatocellular carcinoma
by: Jian Hu, et al.
Published: (2018-12-01)

The Structure and Function of Paraoxonase-1 and Its Comparison to Paraoxonase-2 and -3
by: Ajda Taler-Verčič, et al.
Published: (2020-12-01)

Quantitative glycoproteomics reveals cellular substrate selectivity of the ER protein quality control sensors UGGT1 and UGGT2
by: Benjamin M Adams, et al.
Published: (2020-12-01)

Comparative Evaluation of Alpha-Fetoprotein Serum in Hepatocellular Carcinoma Patients with Non-Viral Etiology
by: Gita Aprilicia, et al.
Published: (2021-03-01)

Evaluation of alpha-fetoprotein as a screening marker for hepatocellular carcinoma in hepatitis prevalent areas
by: Sejong Chun, et al.
Published: (2015-11-01)

Changes in serum α-fetoprotein level predicts treatment response and survival in hepatocellular carcinoma patients and literature review
by: Wen-Chi Chou, et al.
Published: (2018-02-01)

Serum Golgi protein-73 in combination with α-fetoprotein for diagnosing hepatocellular carcinoma in Egyptian patients
by: Mohamed M Makhlouf, et al.
Published: (2017-01-01)

Metabolomic Profiles for HBV Related Hepatocellular Carcinoma Including Alpha-Fetoproteins Positive and Negative Subtypes
by: Jianping Sun, et al.
Published: (2019-10-01)

Racial disparities in alpha‐fetoprotein testing and alpha‐fetoprotein status associated with the diagnosis and outcome of hepatocellular carcinoma patients
by: Guoyi Wu, et al.
Published: (2019-11-01)

Evaluation of serum AFP (α-fetoprotein) level in HBsAg carrier patients for diagnosis of hepatocellular carcinoma
by: eskandar Hajiani, et al.
Published: (2006-06-01)

METHODS DEVELOPMENT IN BIOLOGICAL MASS SPECTROMETRY: APPLICATION IN GLYCOPROTEOMICS
by: Trajkovic, Sanja
Published: (2014)

An Extremely Rare Presentation of an Alpha-Fetoprotein-Producing Esophageal Adenocarcinoma
by: Yaser Khalid, et al.
Published: (2020-10-01)

Extrahepatic metastasis risk of hepatocellular carcinoma based on α-fetoprotein and tumor staging parameters at cross-sectional imaging
by: Yokoo T, et al.
Published: (2017-10-01)

Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation
by: Gauri Mishra, et al.
Published: (2020-05-01)

Differential alternative splicing between hepatocellular carcinoma with normal and elevated serum alpha-fetoprotein
by: Young-Joo Jin, et al.
Published: (2020-12-01)

Clinical Implications of Alpha-fetoprotein in Chronic Hepatitis C
by: Wei-Chen Tai, et al.
Published: (2009-03-01)

Nascent Glycoproteome Reveals That N-Linked Glycosylation Inhibitor-1 Suppresses Expression of Glycosylated Lysosome-Associated Membrane Protein-2
by: Cao, X., et al.
Published: (2022)

Characterizations of Anti-Alpha-Fetoprotein-Conjugated Magnetic Nanoparticles Associated with Alpha-Fetoprotein for Biomedical Applications
by: Shu-Hsien Liao, et al.
Published: (2017-09-01)

Association of Postoperative Biomarker Response with Recurrence and Survival in Patients with Hepatocellular Carcinoma and High Alpha-Fetoprotein Expressions (>400 ng/ml)
by: Liang L, et al.
Published: (2021-03-01)

Comparison of Alpha-Fetoprotein Level in Varying Severity Degree of Hepatocellular Carcinoma Assesed with the Barcelona Clinic of Liver Cancer During 2015-2016 in Haji Adam Malik General Hospital Medan
by: Gontar Alamsyah Siregar, et al.
Published: (2017-04-01)

Detection of Alpha-Fetoprotein in Hepatocellular Carcinoma Patient Plasma with Graphene Field-Effect Transistor
by: Dae Hoon Kim, et al.
Published: (2018-11-01)

Role of PET/CT in patients with unexplained rising alpha fetoprotein post HCC interventional management
by: Samar Ramzy Ragheb, et al.
Published: (2020-04-01)

Characterization of alpha-fetoprotein effects on dendritic cell and its function as effector immune response activator
by: Suryatenggara J, et al.
Published: (2017-11-01)

Early α-fetoprotein response predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib
by: Lee SH, et al.
Published: (2015-04-01)

Evaluation of click chemistry microarrays for immunosensing of alpha-fetoprotein (AFP)
by: Seyed Mohammad Mahdi Dadfar, et al.
Published: (2019-12-01)

Subtle Hepatocellular Carcinoma: A Persisting Role for Alpha-Fetoprotein Monitoring in High-Risk Patients with Cirrhosis
by: Barry Schlansky, et al.
Published: (2011-10-01)